Table 1.
Patient details: type 1 diabetes mellitus (n = 18)
| Age (years) | BMI (kg/m2) | Diabetic complications | HbA1c (range) | Type of insulin | Parity | Gestational age (weeks) | Birthweight (kg) | Caesarean indication | |
|---|---|---|---|---|---|---|---|---|---|
| % | mmol/mol | ||||||||
| 40 | 31.6 | None | 6.1–6.2 | 43–44 | Humulin; humalog | 1 | 38 | 3.69 | Previous CS |
| 40 | 22.3 | None | 5.9–6.4 | 41–46 | Humalog; lantus | 1 | 38 | 3.49 | Maternal request |
| 26 | 28.9 | Retinopathy | 6.4–6.6 | 46–49 | CSII | 0 | 35+2 | 2.18 | Maternal request |
| 24 | 30.1 | Microalbuminuria | 7.9–8.1 | 63–65 | Novorapid, glarginea | 0 | 38 | 3.34 | Previous CS |
| 36 | 24.6 | None | 6.0–7.0 | 42–53 | Novorapid, lantus | 1 | 37+4 | 4.5 | Diabetes |
| CSII | |||||||||
| 36 | 22.4 | Previous nephropathy | 6.5–6.8 | 48–51 | CSII | 1 | 36+4 | 4.42 | Maternal reason |
| 27 | 41.9 | None | 7.9–9.7 | 63–83 | Humalog; lantus | 2 | 35+3 | 4.48 | Diabetes |
| 39 | 30 | Retinopathy | 6.4–8.2 | 46–66 | Humalog; humulin | 0 | 34+0 | 2.58 | Previous CS/maternal request |
| 44 | 31.2 | Vascular | 6.3 | 45 | Insulin | 3 | 36+4 | 2.72 | Maternal reason |
| 29 | 22.3 | None | 5.7–6.3 | 39–45 | Insulin | 1 | 38 | 3.26 | Diabetes |
| 28 | 43 | Nephropathy | 7.1–7.5 | 54–59 | Novorapid, lantus | 3 | 35+2 | 4.37 | Diabetes |
| 34 | 43.8 | None | 6.7 | 50 | Insulin | 1 | 37+1 | 4.31 | Previous CS |
| 37 | 22.6 | Retinopathy | 6 | 42 | Novorapid, lantus | 3 | 32+6 | 2.48 | Maternal reason |
| 38 | 25.2 | Hypertension | 6.5 | 48 | Novorapid, lantus | 3 | 36+3 | 4.115 | Previous CS |
| 27 | 24.2 | None | 5.9 | 41 | CSII | 3 | 33+5 | 2.46 | Breech |
| 41 | 46.2 | Hypertension | 6.1 | 43 | Novorapid, lantus | 1 | 37.5 | 3.29 | Previous CS |
| 36 | 24.8 | Retinopathy and nephropathy | 5 | 31 | Novorapid, lantus | 0 | 37 | 3.27 | Diabetes |
| 40 | 36.5 | None | 5.5–6.0 | 37–42 | Novorapid | 2 | 38 | 3.75 | Previous CS |
aInsulin glargine (A21Gly,B31Arg,B32Arg human insulin)